Manufacturing Plant in Oman for Anti-Cancer Medicine
13 Aug, 2020
A Pharma Group Company in Oman is in the process of setting up a manufacturing plant for Anti-Cancer medicine for the Global Market. The cost of the…
Read more
22 Feb, 2025
Project Feasibility Study, Business Plan and Investment Management for a drug manufacturing factory located in Sohar Industrial Area of Oman mainly engaged in the research, development, production and trade of Active Pharma Ingredients (APIs) and Intermediates for Cephalosporins. The facility is poised to grow rapidly being the only facility in the Middle East for the Cephalosporin APIs and Intermediates. The main products include Cedfixime Trihydrate, Cefuroxime Axetil, Cefdinir Monohydrate along with 7-AVCA.
← More Pharmaceutical projects
13 Aug, 2020
A Pharma Group Company in Oman is in the process of setting up a manufacturing plant for Anti-Cancer medicine for the Global Market. The cost of the…
Read more13 Aug, 2020
A Pharma Company in Oman is setting up a manufacturing plant for a Key Start-Up Material for Antibiotic Drugs for the Global Market. The cost of the…
Read moreGCCA provides feasibility studies, business plans, financial modelling and investor sourcing.
Contact us